Stage II Breast Cancer Recruiting Phase 3 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02445391Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant ChemotherapyTreatment